Search

Author/Creator Colgan, Joseph

1. A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy. Issue 5 (22nd March 2017)

Authors:
Rosenthal, Allison; Dueck, Amylou C.; Ansell, Stephen; Gano, Katherine; Conley, Christopher; Nowakowski, Grzegorz S.; Camoriano, John; Leis, Jose F.; Mikhael, Joseph R.; Keith Stewart, A.; Inwards, David; Dingli, David; Kumar, Shaji; Noel, Pierre; Gertz, Morie; Porrata, Luis; Russell, Stephen; Co...
Journal:
American journal of hematology
Issue:
Volume 92:Issue 5(2017:May)
Page Start:
467
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress. (6th November 2014)

Authors:
Lin, Yi; Atwell, Thomas; Weisbrod, Adam; Maas, Mary; Armstrong, Adam; Deeds, Michael; Bulur, Peggy; Gustafson, Michael; Zhang, Zhe; Porrata, Louis; Markovic, Svetomir; Johnston, Patrick; Micallef, Ivana; Inwards, David; Colgan, Joseph; Ansell, Stephen; Gastineau, Dennis; Dietz, Allan; Witzig, Thomas
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗